CK19-1904 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES (ELC)
$1,007,746,374
AI Summary
This $1.0 billion cooperative agreement from HHS funds the Ohio Department of Health's epidemiology and laboratory capacity for preventing and controlling emerging infectious diseases. The program supports Ohio's public health infrastructure for disease surveillance, laboratory testing, and outbreak response.
Key Points
- 01Funded at approximately $1.0 billion through the ELC program
- 02Supports infectious disease prevention and control in Ohio
- 03Active from August 2019 through July 2027
- 04Administered by the Ohio Department of Health
- 05Strengthens disease surveillance and laboratory testing capacity
Award Details
Official Source
View on USAspending.govAd Space (inline)
Related Awards
Department of DefenseAug 1, 2016
OtherHealthcare
IGF::OT::IGF
$51.2B
HUMANA GOVERNMENT BUSINESS INC
Department of DefenseAug 1, 2016
OtherHealthcare
IGF::OT::IGF MANAGED CARE SUPPORT SERVICES IN SUPPORT OF THE TRICARE PROGRAM
$23.5B
HEALTH NET FEDERAL SERVICES, LLC
Department of DefenseFeb 1, 2023
OtherHealthcare
TRICARE MANAGED CARE SUPPORT SERVICES CONTRACT, 5TH GENERATION EAST REGION
$5.3B
HUMANA GOVERNMENT BUSINESS INC
Department of DefenseJan 1, 2024
OtherHealthcare
TRICARE MANAGED CARE SUPPORT SERVICES CONTRACT, 5TH GENERATION WEST REGION
$4.4B
TRIWEST HEALTHCARE ALLIANCE CORP
Quick Summary
- Amount
- $1.0B
- Agency
- Department of Health and Human Services
- Recipient
- OHIO DEPARTMENT OF HEALTH
- Type
- Other
From the Civic Digest Network
Ad Space (rectangle)